ANAVEX2-73 Study in Patients With Rett Syndrome

NCT03941444 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Rett Syndrome

Interventions

DRUG: ANAVEX2-73
DRUG: Placebo

Sponsor

Anavex Life Sciences Corp.